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Abstract
Objective: To explore the preferences of competent patients with advanced lung cancer regarding involvement
of family and/or others in their medical decision-making, and their future preferences in case of loss of competence.
Methods: Over 1 year, physicians in 13 hospitals in Flanders, Belgium, recruited patients with initial non-small–
cell lung cancer, stage IIIb or IV. The patients were interviewed with a structured questionnaire every 2 months
until the fourth interview and every 4 months until the sixth interview.
Results: At inclusion, 128 patients were interviewed at least once; 13 were interviewed 6 consecutive times.
Sixty-nine percent of patients wanted family members to be involved in medical decision-making and this
percentage did not change significantly over time. One third of these patients did not achieve this preference.
Ninety-four percent of patients wanted family involvement if they lost competence, 23% of these preferring
primary physician control over decision-making, 41% shared physician and family control, and 36% primary
family control. This degree of preferred family involvement expressed when competent did not change signif-
icantly over time at population level, but did at individual level; almost half the patients changed their minds
either way at some point during the observation period.
Conclusions: The majority of patients with lung cancer wanted family involvement in decision-making, and
almost all did so in case of future loss of competence. However, as half of the patients changed their minds over
time about the degree of family involvement they wanted if they lost competence, physicians should regularly
rediscuss a patient’s preferences.
Introduction
Respect for patient autonomy requires physiciansto take into account a patient’s preferences regarding
medical decision-making, including the preference to involve
the family. Considering end-of-life decisions, for instance
(e.g., resuscitation, balance of lucidity and analgesia, site of
terminal care etc.), might be a serious burden on the patient
and require support from trusted family members or close
friends.1
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At the point where the patient is no longer able to make
medical decisions, the physician is confronted with a more
complex problem: if he wants to respect the patient’s pref-
erences about decisions that must be made, their preferences
must be clear and the physician may rely on information
received from the patient when competent, sometimes in the
form of written advance directives, or on the family of the
patient, who are assumed to know them well.2 However, not
all medical situations that may arise can be dealt with in
advance care planning, nor can it be taken for granted that
the family knows the patient’s preferences.3,4 Therefore it
has been suggested that physicians should not only pay at-
tention to the preferences of the patient in relation to specific
medical situations that might arise, but also to how the pa-
tient wants medical decisions to be made if he should lose
competence, e.g., does the patient wish other people to be
involved, who does he wish to be involved and to what
degree?5,6
To examine the involvement of family and/or other peo-
ple in medical decision-making from the perspective of
the patient’s preferences, we investigated advanced lung
cancer patients during the course of their disease. The re-
search questions were:
1. Who do patients with advanced lung cancer want to
involve in medical decision-making while they are
competent and are these persons involved?
2. Who do patients with advanced lung cancer want to
involve in medical decision-making when they are no
longer able to make decisions themselves, and to what
degree?
Methods
Consecutive patients with non-small–cell lung cancer
(NSCLC), stage IIIb or IV, were recruited by pulmonologists
and oncologists at 13 hospitals in Flanders, Belgium, over 1
year. The patients were interviewed by trained interviewers
using a structured questionnaire every 2 months until
the fourth interview and every 4 months until the sixth
interview.
Measurements
Patients were asked whether they wanted others involved
in their medical decision-making both while they were com-
petent and if they lose competence in the future, and were
asked to select one or more of four possible answers: nurse,
family/close friends, no one, other. Patients were also asked
whether these people were actually involved. On the as-
sumption of future loss of competence, patients were asked to
indicate the extent to which they wanted others involved,
choosing one of five possible options representing three
categories: a preference for primary physician, shared physi-
cian-representative(s) and primary representative(s) control
over decision-making. This item is an adaptation of the con-
trol preference scale that has been used in other studies.7,8
Quality of life was measured with the Dutch version of the
EORTC QLQ-C15-PAL.9,10 The patient interview was pilot-
tested and the items were well understood and accepted.
Sociodemographic and clinical characteristics were collected
upon inclusion in the study.
Ethics
The protocol of the study was approved by the Ethical
Review Boards of all the participating hospitals.
Statistical analysis
The characteristics of the patients collected upon inclu-
sion and the quality of life measured during the interviews
were tested for association with the involvement preferences
with the Fisher’s exact test or Mann-Whitney U and entered in
FIG. 1. Participation in study of patients with non-small–cell lung cancer, stage IIIb or IV.
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multivariate models (random coefficient analysis), together
with time (in days since inclusion).11,12
Results
Upon inclusion, 128 patients (68% participation rate) were
interviewed for the first time and 13 were interviewed six
consecutive times. Figure 1 shows the progression of mor-
tality and loss to follow-up. The characteristics of the patients
upon inclusion are reported in Table 1.
Involvement of others when the patient
is competent
At the first interview, 68.8% of patients wanted family to be
involved in medical decision-making, 0.0% nurses and 1.6%
other; 29.7% wanted no one involved (Fig. 2). These percent-
ages did not change significantly over time until 15 months
after inclusion (results of random coefficient analyses), but
there were changes at an individual level (not shown in Fig. 2).
For example, 17.6% of patients changed their preference for
family involvement from not wanting to wanting involve-
ment or vice versa between the first and second interview.
Predictors of wanting versus not wanting family involvement
were: having a partner (odds ratio [OR]: 4.8, p: 0.027, confi-
dence interval [CI]:1.2–19.5) and having a lower level of
physical functioning (OR: 0.98, p: 0.008, CI: 0.96—0.99).
Of the patients who wanted family involvement in
decision-making at the first interview, a proportion of
68.2% reported that they had actually achieved this pref-
erence and of those who wanted no one involved, 86.8%
had achieved it. The achievement rates were similar in
subsequent interviews (Fig. 2).
Involvement of others when the patient
is incompetent
A total of 93.6% of patients wanted family to be involved in
decision-making if they were to become incompetent, 0.8%
wanted nurses involved, and 6.4% wanted no one. Of the pa-
tients who wanted their family involved at the time of the first
interview, 22.6% wanted primary physician control, 40.9%
shared physician–family control, and 36.5% wanted primary
family control. At population level, the time since inclusion had
no significant impact on this degree of preferred involvement
(Table 2). There were, however, changes over time at an indi-
vidual level: 49.4% changed their preferred role for family be-
tween the first and second interview and these percentages
were similar between the next subsequent interviews (40.0%,
38.1%, 42.9%, and 50.0%). Female patients, those whose emo-
tional functioning was better or improved and those with pain
were more likely to want shared physician–family control or
primary family control rather than primary physician control
over decision-making (Table 2).
Discussion
This study succeeded in including 128 patients with ad-
vanced lung cancer. Two thirds of the patients wanted family
involvement in medical decision-making alongside their
own involvement and that of the physician. This is similar to
the finding in a study of 50 patients with a malignant disease
in Germany.13 What is new in our study is that this propor-
tion of patients did not change significantly over time after
diagnosis.
Of the patients who wanted family involvement, one third
reported that they had not achieved this. Reasons for not
achieving concordance are not clear, and probably include
families who are not able or willing to cooperate or patients
who want to avoid burdening their families.14 A finding of
particular interest is that patients with a partner were signif-
icantly more likely to want family involvement in decision-
making. This suggests that patients without a partner might
be at increased risk of having no one to make decisions for
Table 1. Characteristics of the Patients
with Advanced Lung Cancer Studied
at the Time of Inclusion (n¼ 128)
Mean (SD)
Age 64.4 (9.7)
n (%)
Gender
Male 102 (79.7)
Female 26 (20.3)
Partner
Yes 98 (76.6)
No 30 (23.4)
Home circumstances
Living at home alone 31 (24.2)
Living at home with others 97 (75.8)
Education
Primary school 24 (18.8)
Lower secondary 42 (32.8)
Higher secondary 40 (31.2)
University 22 (17.2)
Religion
Religious 93 (72.7)
Not religious 35 (27.3)
Treating hospital
University 59 (46.1)
General 69 (53.9)
Type of treatment
Chemotherapy 105 (82.0)
Radiotherapy 41 (32.0)
Contact with GPa
Once a week or more 11 (8.6)
Once every 2 weeks 17 (13.3)
Once every month 59 (46.1)
Less 41 (32.0)
Comorbidityb
0 65 (50.8)
1–2 53 (41.4)
3–4 10 (7.8)
Performance statusc
0 31 (24.2)
1 81 (63.3)
2 11 (8.6)
3 3 (2.3)
4 2 (1.6)
Mean (SD)
Life expectancy on inclusiond 10.6 (4.5)
aThree patients reported that they did not have a GP. They were
included in the category ‘‘Less.’’
bComorbidity score using Charlson Index.
cPerformance status according to ECOG: Eastern Cooperative
Oncology Group, ranging from 0¼ fully active to 4¼ completely
disabled.
dEstimated by treating physician.
SD, standard deviation; GP, general practioner.
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them, and thus perhaps need more intensive advance care
planning up front.
Practically all patients wanted family involvement if they
were to become incompetent and a large majority of these
wanted the involvement to be substantial: 41% preferred
shared family–physician control, 36% primary family control,
and only 23% primary physician control. This is comparable
with the finding of a U.S. study in which patients with recent
diagnoses of terminal illnesses had to weigh the physician’s
input against the input of family in decision-making.15 A
possible explanation is that when patients with advanced
cancer lose competence, medical decisions are often end-of-
life decisions, which are viewed as far more personal than, for
example, treatment decisions.
Although the degree of preferred involvement of family in
the event of incompetence did not change significantly over
time at population level, it did at individual level: almost half
of the patients changed their preference at some time between
interviews (at intervals of 2 months), toward either more or
less family involvement. This finding illustrates the impor-
tance of the physician’s skills in family communication and
implies that physicians should regularly rediscuss a patient’s
preferred degree of family involvement in the event of loss of
competence, or that the physician should tell the patient that a
change in preference is not uncommon and can always be
communicated to them.16,17
It is noteworthy that although many patients wanted their
family involved in decision-making whether they were com-
FIG. 2. Percentage at interview 1 to 6 of patients with advanced lung cancer who wanted and achieved involvement of
others in medical decision-making (while they were competent).
Table 2. Predictors of Advanced Lung Cancer Patients Wanting Shared Doctor-Family Control
and Primary Family Control, Versus Primary Doctor Control (in the Event of Incompetence)
Number of level 1 units¼ 329
Number of level 2 units¼ 116
Log likelihood¼326.49111 Odds ratioa Std Error p value 95% Conf interval
Predictors of wanting shared doctor-family
control (versus doctor control)
Time since inclusionb 0.997 0.001 0.095 0.995–1.000
Gender of patient Female 5.647 3.776 0.010 1.523–20.943
Male (Ref) — — — —
Emotional functioningc 1.018 0.008 0.018 1.003–1.033
Painc 1.020 0.007 0.005 1.006–1.034
Predictors of wanting family control
(versus doctor control)
Time since inclusionb 0.998 0.001 0.178 0.995–1.009
Gender of patient Female 7.404 0.680 0.003 1.952–28.078
Male (Ref) — — — —
Emotional functioningc 1.027 0.008 0.001 1.010–1.537
Painc 1.020 0.007 0.006 1.006–1.412
aOdds ratio resulting from random coefficient analysis.
bTime: in days since inclusion (entered as continuous variable).
cScales of the EORTC QLQ-C15-PAL with scores from 0 to 100 (entered as continuous variable).
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petent or not, very few wanted nurses involved. This might
be in contrast to the findings of studies focusing on actual
decision-making in terminal care, where nurses do play a
major role.18
Limitations of the study
There were several limitations. First, caution is needed with
generalizing the data beyond the sample: (1) 32% of the eli-
gible patients did not participate and 30% of the patients
dropped out during the follow-up; (2) 80% of the patients in
our sample were male; and (3) the patients studied were
Flemish; culture might have a significant effect on the results.
Second, the high loss to follow-up over time also makes it
difficult to draw conclusions for the long term, i.e., 1 year or
more. Third, patients’ preferences for involvement were ex-
amined with regard to medical decisions in general and using
close-ended questions that did not allow for possible nuances
in their answers.
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